Medicinova Inc. Stock
Medicinova Inc. Stock
With 6 Buy predictions and not the single Sell prediction the community is currently very high on Medicinova Inc..
Based on the current price of 3.22 € the target price of 7 € shows a potential of 117.53% for Medicinova Inc. which would more than double the current price.
Pros and Cons of Medicinova Inc. in the next few years
Pros
?
M***** P*******
?
C******** o* t** e**********
?
W********* I********* f** t** n*** y****
Cons
?
G***** c******* t* c**********
?
S********** s********
?
B****
Tell us your opinion to access the 'Wisdom of the Crowds'
Performance of Medicinova Inc. vs. its peers
| Security | Change(%) | 1w | 1m | 1y | YTD | 3y | 5y |
|---|---|---|---|---|---|---|---|
| Medicinova Inc. | - | - | - | - | - | - | - |
| Heron Therapeutics Inc. | 5.840% | -31.089% | -20.320% | -73.274% | -73.178% | -79.946% | -96.948% |
| Evolus Inc | 1.430% | 35.230% | 25.286% | 50.500% | 32.550% | -18.831% | -21.049% |
| Rhythm Pharmaceuticals | -1.030% | 1.047% | 1.579% | 21.384% | 3.209% | 295.492% | 710.924% |
Comments
MediciNova (MNOV) had its "buy" rating reaffirmed by Maxim Group. They now have a $6.00 price target on the stock.
Show more
Ratings data for MNOV provided by MarketBeat
MediciNova (MNOV) is now covered by HC Wainwright. They set a "buy" rating and a $10.00 price target on the stock.
Show more
Ratings data for MNOV provided by MarketBeat
MediciNova (NASDAQ:MNOV) had its "buy" rating reaffirmed by analysts at D. Boral Capital. They now have a $9.00 price target on the stock.
Show more
Ratings data for MNOV provided by MarketBeat